EcoDrugPlus

Phosphodiesterase 5a, Cgmp-Specific, B

Ensembl ID : ENSIPUG00000017710
Gene Symbol: PDE5AB
3 Cross references
223 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSIPUG00000014264
Gene Symbol: PDE7A
3 Cross references
227 Possible Orthologues:

Phosphodiesterase 9aa

Ensembl ID : ENSIPUG00000005305
Gene Symbol: PDE9AA
3 Cross references
184 Possible Orthologues:

Phosphoinositide-3-Kinase, Regulatory Subunit 1 (Alpha)

Ensembl ID : ENSIPUG00000016974
Gene Symbol: PIK3R1
3 Cross references
202 Possible Orthologues:

Phosphoinositide-3-Kinase, Regulatory Subunit 3b (Gamma)

Ensembl ID : ENSIPUG00000005932
Gene Symbol: PIK3R3B
3 Cross references
245 Possible Orthologues:

Phosphoinositide-3-Kinase, Regulatory Subunit 5

Ensembl ID : ENSIPUG00000003531
Gene Symbol: PIK3R5
3 Cross references
200 Possible Orthologues:

Phospholipase A2 Group X

Ensembl ID : ENSIPUG00000019042
Gene Symbol: PLA2G10
4 Cross references
231 Possible Orthologues:

Phospholipase A2, Group Vii (Platelet-Activating Factor Acetylhydrolase, Plasma)

Ensembl ID : ENSIPUG00000023820
Gene Symbol: PLA2G7
3 Cross references
203 Possible Orthologues:

Phosphoribosylglycinamide Formyltransferase

Ensembl ID : ENSIPUG00000007090
Gene Symbol: GART
3 Cross references
246 Possible Orthologues:

Plasma Kallikrein

Ensembl ID : ENSIPUG00000001517
Gene Symbol: LOC108257413
1 Cross references
214 Possible Orthologues:

Plasminogen

Ensembl ID : ENSIPUG00000020743
Gene Symbol: PLG
3 Cross references
256 Possible Orthologues:

Plasminogen Activator, Tissue

Ensembl ID : ENSIPUG00000024913
Gene Symbol: PLAT
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).